Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

Market Cap	75.00B
Revenue (ttm)	134.14B
Net Income (ttm)	10.11B
Shares Out	5.00M
EPS (ttm)	2,021.91
PE Ratio	7.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600
Average Volume	5,020
Open	15,000
Previous Close	15,000
Day's Range	15,000 - 15,000
52-Week Range	8,100 - 16,800
Beta	0.44
RSI	60.64
Earnings Date	Jan 20, 2026

About HNX:MKV

Cai Lay Veterinary Pharmaceutical Joint Stock Company manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina. The company offers veterinary medicine, aquatic medicine, and animal nutrition. It provides products for cattle, pig, chicken, duck, dog, cat, fish, and other species through distributors and agents. The company was formerly known as Cai Lay Livestock and Veterinary Pharmacy Company and changed its name to Cai Lay Veterinary Pharmaceutical Joint Stock Company. Cai Lay Veterinary Pharmaceutical Joint Stock ...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 104
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MKV

Financial Performance

In 2024, HNX:MKV's revenue was 107.04 billion, a decrease of -3.49% compared to the previous year's 110.91 billion. Earnings were 7.32 billion, an increase of 18.11%.